JACC:经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗

2017-08-15 xiangting MedSci原创

通过ILCs进行逆向CTO PCI是一项具有挑战性的手术,可以在困难性闭塞中实施。

这项研究的目的是描述经同侧旁路通道(ILCs)的逆向慢性完全闭塞(CTO)经皮冠脉介入治疗(PCI)的手术方面和预后。

通过ILCs进行逆向CTO PCI很少见,通常是在没有其他逆向选择的情况下,并且可用证据主要来自病例报告。

这是一项大型的回顾性多国登记研究,其中包括所有在2011年9月至2016年10月间通过ILCs在6个中心进行逆向CTO PCI术的患者。分析了成功率以及手术并发症和院内结局。

共纳入126例患者(占所有逆向CTO PCI的17%)。平均年龄为65.7±11.2岁,平均J-CTO(日本多中心CTO登记)评分为2.36±1.13。靶血管42%为冠脉旋支,39%为左前降支,19%为右冠脉。所用的ILCs 76%为心外膜,24%为隔膜。ILC解剖结构具有异质性。80%使用一个引导导管,20%使用ping-pong技术。81%的逆向导丝可以推进到远端帽。技术和手术成功率分别为87%和82%。5.6%出现需要治疗的ILC穿孔,2.4%由于ILC穿孔出现填塞。1例病人(0.8%)死亡。

通过ILCs进行逆向CTO PCI是一项具有挑战性的手术,可以在困难性闭塞中实施,由经验丰富的操作人员实施成功率高,并发症发生率合理。

原始出处:
Lorenzo Azzalini, et al. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels. JACC: Cardiovascular Interventions. August 2017. 

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2018-07-17 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-15 三生有幸9135

    学习一下谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1853728, encodeId=a7631853e2855, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Jul 17 02:46:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700488, encodeId=f25c1e004880f, content=<a href='/topic/show?id=9f6c535115f' target=_blank style='color:#2F92EE;'>#慢性完全闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53511, encryptionId=9f6c535115f, topicName=慢性完全闭塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c22430117406, createdName=redcrab, createdTime=Mon Feb 26 17:46:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325476, encodeId=c98213254e6d9, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30944, encryptionId=1ed0309444e, topicName=冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8u3mGRpJpSHpz8GnN2RDHUVc5Vm6yUoQhqesfhJoyZjndetgiaQV6z9uzia2U2DkZ8ZWXqJBZTHXxib22b7nngyhw/132, createdBy=f44f5082140, createdName=12498ebem20暂无昵称, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460447, encodeId=cd5f146044ed9, content=<a href='/topic/show?id=f2cde83988e' target=_blank style='color:#2F92EE;'>#经皮冠脉介入治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78398, encryptionId=f2cde83988e, topicName=经皮冠脉介入治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555a6326698, createdName=zhanglin3081, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596079, encodeId=9d8315960e9fa, content=<a href='/topic/show?id=f2c4e8397a7' target=_blank style='color:#2F92EE;'>#经皮冠脉介入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78397, encryptionId=f2c4e8397a7, topicName=经皮冠脉介入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298b18326857, createdName=shock_melon, createdTime=Thu Aug 17 01:46:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233823, encodeId=9a9523382345, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Tue Aug 15 15:14:43 CST 2017, time=2017-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233806, encodeId=4a5f23380693, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Tue Aug 15 12:15:20 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-15 天涯183

    非常好的文章,学习了,很受益

    0

相关资讯

CTO病变经桡动脉入路行ad hoc PCI可行

  2012年世界心脏病学大会公布埃及和我国台湾学者共同开展的一项研究显示:对于慢性完全闭塞(CTO)的病人,经桡动脉入路行ad hoc经皮冠状动脉介入术(PCI)是安全和可行的,成功率和住院转归均可接受。   Ad hoc PCI已成为临床惯例。但还没有人着重研究ad hoc CTO PCIs。为此,作者比较了Ad h